I flere kontrollerede forsøg har epoetiner ikke vist sig at forbedre den samlede overlevelse eller reducere risikoen for tumorprogression hos patienter med anæmi i forbindelse med cancer.
In several controlled studies, epoetins have not been shown to improve overall survival or decrease the risk of tumour progression in patients with anaemia associated with cancer.